Dr. Shishir Seth

Dr. Shishir Seth

Senior Consultant 

26 Years of Experience

Hematologist

MBBS, MD, DM

Reg. No.:28034, Delhi Medical Council

Confirm Your Consultation With Dr. Shishir Seth

Expert Help When You Need It – Plan in 60 Minutes

About Dr. Shishir Seth

  • Dr. Shishir Seth is a renowned Clinical Hematologist with over 26 years of dedicated medical practice.
  • He specializes in treating a wide range of hematological disorders, including Acute Leukemia (AML/ALL), Lymphoma, Multiple Myeloma, CML, CLL, Chronic Myeloproliferative Neoplasms, and Myelodysplastic Syndrome.
  • His expertise also covers conditions such as anemia, Thalassemia, and various bleeding and clotting disorders.
  • Dr. Seth has successfully performed over 150 Hematopoietic Bone Marrow Transplant (BMT) procedures.
  • Out of these, 40 procedures were allogenic transplants, including haplo-identical and antigen mismatch transplantations.
  • Throughout his career, he has conducted more than 300 induction therapies for patients with acute leukemia.
  • He completed his MBBS from Chaudhary Charan Singh University, Meerut in 1999.
  • He went on to pursue an MD in Pathology from the University of Mumbai in 2005.
  • He earned his DM in Clinical Hematology from Maharashtra University of Health Sciences, Nashik, in 2009.
  • Dr. Seth is actively involved in research and has published extensively in both national and international medical journals.
  • He holds a Life Membership with the Indian Society of Haematology and Transfusion Medicine.
  • Additionally, he is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Confirm Your Consultation With Dr. Shishir Seth

Expert Help When You Need It – Plan in 60 Minutes

Education

  • MBBS, Chaudhary Charan Singh University, Meerut, 1999
  • MD (Pathology), University of Mumbai, Mumbai, 2005
  • DM (Clinical Hematology), Maharashtra University of Health Science, Nashik, 2009

OPD Schedule Of Dr. Shishir Seth

Book Appointment

Past Experience

  • Consultant, Rajiv Gandhi Cancer Institute, 2013
  • Fellow, British Columbia Cancer Agency, 2012
  • Senior Resident, Seth G.S. Medical College & KEM Hospital, 2011
  • Consultant, Moolchand Hospital, 2006
  • Senior Resident, GTB Hospital, 2005
  • Clinical Assistant, PD Hinduja National Hospital, 2005
  • Senior AMO, Bombay Hospital 
  • Junior Resident, Seth G.S. Medical College & KEM Hospital, 2004
  • Successfully performed over 150 Hematopoietic stem cell Transplants (BMT), 40% of which were allogeneic, including Haplo-identical and antigen mismatch transplants.
  • Performed more than 300 induction Therapies for Acute Leukaemia.
  • An unusual presentation of pediatric acute lymphoblastic leukemia. Indian J Hematol Blood Transfuse, 2008;24(2) 59-62.
  • “Spectrum of Small Intestinal Lymphoma in Western India” in International Conference on Emerging Trends in Haematology and Immuno hematology at Mumbai, India.
  • “Chronic Myeloid Leukemia: Demographic and Clinical Profile from a Tertiary Center in Western India” in Leukemias: Molecular insights to treatment Paradigms at Mumbai.
  • Hematopoietic Cell Transplantation in Lymphoma: Why & When; Evidence-Based Review. Cancer News, Dec, 2011.
  • “Lymph node and Tuberculosis: Clinical, Pathological and Microbiological Correlation.” In CYTOCON-2003 at Pune, India
  • “Spectrum of small intestinal lymphoma in western India” at an international conference on emerging trends in hematology and immuno-hematology in Mumbai, India.
  • “Chronic Myeloid Leukaemia: Demographic and clinical profile from a tertiary center in western India” in Leukaemias: molecular insights to treatment paradigms at Mumbai.
  • Hematopoietic Cell Transplantation in Lymphoma: Why & When; Evidence-Based Review. Cancer News, Dec 2011; 5(5) 10-12
  • Acute Myeloid Leukaemia- An Update, RGCI Newsletter-External- Mar 2012; 16(3) 2-3.
  • Performed more than 300 induction Therapies for Acute Leukaemia.
  • Successfully performed over 150 Hematopoietic stem cell Transplants (BMT), 40% of which were allogeneic, including Haplo-identical and antigen mismatch transplants.